Delayed Vaccines Intensify DRC’s Mpox Challenge

The Democratic Republic of the Congo (DRC) remains at the centre of a severe mpox outbreak, with 19 710 suspected cases and 655 deaths reported in 2024.

The World Health Organization (WHO) declared the outbreak a global public health emergency last month, aiming to mobilise a robust international response. Despite this, hospitals in regions like Kavumu are struggling with overcrowded facilities and severe shortages of medicine and supplies.

Vaccines are expected to arrive in the DRC within the upcoming days, following efforts by the United Nations Children’s Fund and its partners, including the Gavi Vaccine Alliance, the Africa Centres for Disease Control and Prevention, and WHO.

This coalition has issued an emergency tender to secure up to 12 million doses by 2025, depending on manufacturing capacities. WHO is also reviewing emergency use listings for vaccines from Bavarian Nordic and Japan’s KM Biologics, with decisions anticipated by mid-September.

WHO Director-General, Tedros Adhanom Ghebreyesus, expressed optimism that the outbreak could be halted within six months with coordinated efforts. However, the DRC’s challenges – including a lack of resources and delayed vaccine deliveries – highlight the urgent need for international support to combat the rapidly spreading virus.

Image Credit: Source